Genenta Science SpA
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +0.0% | +157.3% | +25.6% | +591.4% | +4.9% | -36.9% | |
| – | -38.6% | +8.0% | +45.4% | +2.4% | +14.5% | +19.2% | |
| – | -38.2% | +74.4% | +0.0% | – | – | – | |
| – | -168.0% | – | – | -273.8% | – | -191.9% | |
| – | +0.0% | -56.8% | +200.5% | -49.1% | -67.6% | +70.7% | |
| – | +0.0% | -56.8% | +200.5% | +54,915.4% | – | -311.3% | |
| – | – | – | – | – | – | – | |
| – | -90.6% | +1,968.8% | -100.0% | – | +50,914.1% | +8,127.6% | |
| – | -138.1% | – | -134.2% | – | – | +6.2% | |
| – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.